# Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma

> **NCT00550797** · PHASE2 · COMPLETED · sponsor: **Syntara** · enrollment: 18 (actual)

## Conditions studied

- Allergic Asthma

## Interventions

- **BIOLOGICAL:** TPI ASM8
- **BIOLOGICAL:** placebo

## Key facts

- **NCT ID:** NCT00550797
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00550797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00550797, "Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00550797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*